Working with Auditory HEI-OC1 Cells

摘要

House Ear Institute-Organ of Corti 1 （HEI-OC1） 是目前可用于研究目的的少数小鼠听觉细胞系之一。该方案描述了如何使用 HEI-OC1 细胞来研究药物的细胞毒性作用以及内耳蛋白的功能特性。

摘要

HEI-OC1 是为数不多的可用于研究目的的小鼠听觉细胞系之一。这些细胞最初被提议作为筛选耳毒性药物的体外系统，已被用于研究药物激活的凋亡途径、自噬、衰老、细胞保护机制、炎症反应、细胞分化、药物的遗传和表观遗传效应、缺氧的影响、氧化和内质网应激以及分子通道和受体的表达。在耳蜗毛细胞的其他几个重要标志物中，HEI-OC1 细胞内源性表达 prestin，这是外毛细胞的典型运动蛋白。因此，它们对于阐明这种重要听觉蛋白的新功能方面非常有用。HEI-OC1 细胞非常健壮，其培养通常不会出现大的并发症。但是，它们需要一些特殊条件，例如避免使用含有链霉素或其他抗生素的常见抗菌混合物，以及在 33 °C 下孵育以刺激细胞增殖，并在 39 °C 下孵育以触发细胞分化。在这里，我们描述了如何培养 HEI-OC1 细胞以及如何在一些典型的检测中使用它们，例如细胞增殖、活力、死亡、自噬和衰老，以及如何进行膜片钳和非线性电容测量。

引言

House Ear Institute-Organ of Corti 1 (HEI-OC1) cells are derived from the auditory organ of a transgenic mouse ^1,2. Incubation of any cell from this transgenic mouse at 33 °C/10% CO₂ (permissive conditions) induces expression of an immortalizing gene that triggers de-differentiation and accelerated proliferation; moving the cells to 39 °C/5% CO₂ (non-permissive conditions) lead to decreased proliferation, differentiation and, at least in the case of HEI-OC1, cell death ^2,3.

HEI-OC1 cells were cloned and characterized in our laboratory over a decade ago, and initial studies indicated that they express specific markers of cochlear hair cells, such as prestin, myosin 7a, Atoh1, BDNF, calbindin and calmodulin, but also markers of supporting cells like connexin 26 and fibroblast growth factor receptor (FGF-R) ². Therefore, it was suggested that HEI-OC1 could represent a common progenitor for sensory and supporting cells of the organ of Corti ². Parallel studies provided strong evidence that archetypal ototoxic drugs like cisplatin, gentamicin and streptomycin induced caspase-3 activation in these cells, while drugs considered non-ototoxic, like penicillin, did not ^2,3. Therefore, this cell line was proposed as an in vitro system to investigate the cellular and molecular mechanisms involved in ototoxicity and for screening of the potential ototoxicity or otoprotective properties of new pharmacological drugs. It is estimated that HEI-OC1 cells have been used in more than one hundred and fifty studies published in the last ten years.

Whereas looking at the potential pro-apoptotic effect of different drugs was the major goal of most of the studies involving this cell line, other important cell processes like autophagy and senescence have just started to be investigated in HEI-OC1 cells^4-7. In a recent study from our laboratory ⁸, we used HEI-OC1 cells to collect a comprehensive set of data about cell death, survival, proliferation, senescence and autophagy induced by different pharmacological drugs frequently used in the clinic. We also compared some of the responses of HEI-OC1 cells with those from HEK-293 (human embryonic kidney cells) and HeLa (human epithelial cells) receiving identical treatment. Our results indicated that HEI-OC1 cells respond to the each drug in a characteristic way, with a distinctive dose- and time-dependent sensitivity to at least one of the mechanisms under study. We also emphasized in that study that a correct interpretation of the experimental results will require performing parallel studies with more than one technique ⁸.

In a different study we investigated the use of HEI-OC1 cells to evaluate the functional response of prestin, the motor protein of cochlear outer hair cells (OHCs) ⁹. We reported flow cytometry and confocal laser scanning microscopy studies on the pattern of prestin expression, as well as nonlinear capacitance (NLC) and whole cell-patch clamping studies in HEI-OC1 cells cultured at permissive (P-HEI-OC1) and non-permissive (NP-HEI-OC1) conditions. Our results indicated that both total prestin expression and plasma membrane localization increase in a time-dependent manner in NP-HEI-OC1 cells. Interestingly, we also found that the increase in prestin localization at the plasma membrane of NP-HEI-OC1 cells correlated with a decrease in Na⁺K⁺ATPase, which translocated from the plasma membrane to the cytoplasm without significant changes in total cell expression. In addition, we demonstrated that P-HEI-OC1 cells have a robust NLC associated to prestin motor function, which decreased when the density of prestin molecules present at the plasma membrane increased. Altogether, these results strongly support the usefulness of HEI-OC1 cells to investigate auditory proteins.

In this video article we describe how to culture HEI-OC1 cells, why it is convenient to use cells growing at permissive conditions (P-HEI-OC1) for cytotoxicity studies, how to evaluate the mechanism/s of drug-induced cytotoxicity and how to perform electrophysiological studies (e.g., patch-clamp, non-linear capacitance (NLC)) to investigate functional properties of prestin, the molecular motor of cochlear OHCs.

方案

1. Cell Culture

Note: All cell culturing protocols must be performed using proper cell culture techniques (for reference see the first 3 Chapters of Cell Biology: A Laboratory Handbook, Volume I ¹⁰). HEI-OC1 cells do not require any additional coating or treatment of the cell culture dishes for proper adherence and growth. Very important: do not use glassware dishes for cell culture purposes; the phenotype and biological response of the cells to pharmacological drugs will change (G Kalinec & F Kalinec, unpublished); conventional plastic cell culture dishes are recommended (see Table of Materials/Equipment). Pay special attention to aseptic techniques to avoid contaminations, but never use antibiotics (e.g., ampicillin or streptomycin) with HEI-OC1 cells. If necessary, use amphotericin B. While HeLa and HEK-293 cells have been used as control in previous studies with HEI-OC1 ⁸, any other cell line could be acceptable for this purpose.

1. Resuscitation of Frozen HEI-OC1 Cells
   Note: This protocol can also be used with other cell lines from the same transgenic mouse developed in our laboratory, such as OC-k3, from organ of Corti ^11,12, and SV-k1, from stria vascularis ^13,14.
   1. Remove a vial of cryopreserved HEI-OC1 cells from liquid N₂, and place it in a water bath at 37 °C. Submerge only the lower half of the vial, and allow it to thaw until only a small amount of ice remains in the vial. Wipe the outside of the vial with 70% alcohol.
   2. Pipette the cells from the vial and deliver the entire volume (~ 1.5 x 10⁵ cells/ml) slowly, drop by drop, into a 15 ml conical tube containing 10 ml of a pre-warmed growth medium, like Dulbecco's Modified Eagle's Medium (DMEM), supplemented with 10% fetal bovine serum (FBS).
   3. Remove DMSO by centrifuging the tube at 300-500 x g for 5 min, discarding the supernatant and re-suspending the cells in 9 ml of fresh growth medium (DMEM + 10% FBS). Disaggregate clumps or sheets of cells by flux and reflux of the suspended cells, from the pipette to the medium and vice-versa, three to four times with the tip of the pipette touching the bottom of the tube.
   4. Place the total volume of cells suspended in growth medium in 100 mm-diameter untreated, plastic cell culture dishes.
   5. Incubate the cells at 33 °C with 10% CO₂ (permissive conditions).
2. Subculture of HEI-OC1 Cells
   Note: Prior to confluence (~80%) the cells should be brought into suspension and sub-cultured in order to prevent the culture dying. This protocol can also be used with other cell lines developed in our laboratory from the same transgenic mouse, such as OC-k3, from organ of Corti ^11,12, and SV-k1, from stria vascularis ^13,14.
   1. Remove old medium and wash the cells with 2 ml of PBS.
   2. Cover the cell monolayer with a solution of 0.25% trypsin, using 1 ml per 25 cm² of surface area. To move onto the next step more than 40% of the cells must be detached. Examine the cells using an inverted microscope and, if necessary, "slap or tap" the culture dishes gently to release any remaining attached cells.
      Note: Take care as trypsinization for long periods can cause cell death; not enough and the transferred cells will insufficient for the planned studies.
   3. Resuspend the cells, following the procedure described in 1.1.3, and transfer them to a 15 ml conical tube.
   4. Centrifuge for 5 min at 300-500 x g, discard the medium, collect the cells with fresh growth medium and seed them in, at least, four 100 mm-diameter cell culture dishes. The number of cells per dish will depend on the amount of cells recovered. Incubate the cells at 33 °C with 10% CO₂ (P-HEI-OC1) and divide again as many times as necessary for the planned experiments or for generating a new stock.
   5. For stock preparation, replace 100 mm-diameter dishes by 250-550 ml cell culture flasks; for experiments, smaller dishes or multi-wells plates may be more adequate.
   6. For differentiation, incubate HEI-OC1 cells at permissive conditions until they reach ~80% confluence; then move the dishes to 39 °C with 5% CO₂ (NP-HEI-OC1) for 2 to 3 weeks.
      Note: Cells will progressively stop proliferating and dying. Change the medium every other day to remove dead cells. Depending on the original number of cells, usually after ~ 4 weeks no more cells will be available for experiments. Differentiation starts as soon as the cells are placed at NP conditions, but not every cell differentiate at the same pace. Importantly, prestin expression and membrane localization increases during the differentiation process (see Representative Results, Figure 4), providing a qualitative and quantitative indication of the level of differentiation.

2. Drug Cytotoxicity Studies

Note: HEI-OC1 cells grown at permissive conditions (P-HEI-OC1) are recommended for these studies (see Representative Results, Figure 1).

1. Cell Viability (MTT Assay)
   1. Collect P-HEI-OC1 cells by following the procedure described in 1.2, and count them with either an automatic cell counter or hemocytometer. Adjust the concentration to 2.0 x 10⁵ cells/ml.
   2. Seed the cells on 96-well clear flat bottom plates (100 µl per well), incubate overnight for attachment to the substrate, and then treat them with the drugs of interest. Do not forget to include blanks and non-treated cells (control)!
   3. After drug treatment (usually 24 or 48 hr at 33 °C), perform the MTT assay following the manufacturer's protocol. In general, the protocols for this assay have the following steps:
      1. Add 10 µl of MTT reagent to each well.
      2. Incubate the plate at 37 °C for 2 to 4 hr until purple dye is visible, and then add 100 µl of the MTT Detergent Reagent to each well. Do not shake the plate.
      3. Cover the plate and leave it in the dark for 2 to 4 hr at 37 °C.
      4. Use a microplate plate reader to measure absorbance at 570 nm in each well, including the blanks (growth medium alone). Normalize data using the average OD in control cells as 100% of viability.
2. Caspase 3/7 Activation Assay
   Note: HEI-OC1 cells grown at permissive conditions (P-HEI-OC1) are recommended for these studies.
   1. Collect HEI-OC1 cells by following the procedure described in 1.2, and count them with either an automatic cell counter or a hemocytometer. Adjust the concentration to 2.0 x 10⁵ cells/ml.
   2. Seed the cells on white-walled 96-well plates (100 µl per well), incubate overnight for attachment to the substrate, and then treat them with the drugs of interest. Do not forget to include blanks and non-treated cells (control)!
   3. After drug treatment (usually 24 or 48 hr at 33 °C), perform the caspase assay following the respective manufacturer's protocol. In general, the protocols for this assay have the following steps:
      1. Prepare the reagents, mix them well, and allow them to equilibrate to room temperature.
      2. Remove the cells from the incubator and allow the plates to equilibrate to room temperature.
      3. Add the indicated amount of reagent to each well, being careful to avoid cross-contamination by not touching wells containing different samples with the same pipette tips.
      4. Cover the plate and mix for 30 sec using a plate shaker at 300-500 rpm.
      5. Incubate the plate at room temperature for a period of, at least, 30 min. Determine the optimal incubation period empirically. If the room temperature fluctuates use a constant-temperature incubator, because temperature fluctuations will affect luminescence reading.
      6. Measure luminescence in each well, and normalize values using average luminescence in control cells as 100% of caspase activation.
3. Cell Division (Proliferation)
   1. Collect HEI-OC1 cells by following the procedure described in 1.2, and count them with either an automatic cell counter or a hemocytometer. Adjust the concentration to 2.0 x 10⁵ cells/ml.
   2. Seed the cells on 96-well clear flat bottom plates (100 µl per well), incubate overnight at permissive conditions for attachment to the substrate, and then treat them with the drugs of interest. Don't forget to include blanks and non-treated cells (control)!
   3. One hour after treatment, add to each well 1 µl of prepared 100x BrdU (5-Bromo-2′-deoxyuridine) solution, and return the plates to the incubator at 33 °C.
   4. After 12, 24 and 48 hr, remove the existing medium from the corresponding plates and wash each well once with PBS.
   5. Perform the cell proliferation assay following the manufacturer's protocol. In general, the protocols for this assay have the following steps:
      1. Prepare the reagents, including fixing/denaturing solution, wash buffer, primary antibody detection solution, secondary antibody detection solution, and BrdU solution as indicated in the manufacturer's protocol.
      2. Add the fixing/denaturing solution to each well, in the amounts indicated in the manufacturer's protocol, and keep the plate at room temperature for 30 min.
      3. Remove the fixing/denaturing solution and add the primary antibody at the concentration indicated in the manufacturer's protocol. Keep the plate at room temperature for 1 hr.
      4. Remove the solution with the primary antibody, wash the plate 3 times with wash buffer, and then add the secondary antibody at the concentration indicated in the manufacturer's protocol. Keep the plate with the secondary antibody at room temperature for 30 min.
      5. Remove the solution with the secondary antibody, wash the plate 3 times with wash buffer, and add the substrate. After 10 min incubation at room temperature, add the STOP solution. Be careful: Control the change in color; if the solution becomes very dark, stop the reaction prior to the standard development time of 10 min.
      6. Read absorbance at 450 nm within 30 min of adding the STOP Solution.
4. Cytotoxicity
   Note: HEI-OC1 cells grown at permissive conditions (P-HEI-OC1) are recommended for these studies.
   1. Incubate at permissive conditions, usually for 24-48 hr, HEI-OC1 cells in cell culture medium alone (control) or medium plus the drugs of interest.
   2. At the end of the treatment, wash the cells three times with PBS, and detach using 1 ml per 25 cm² of surface area of a non-enzymatic cell dissociation solution for 3 min.
   3. After detaching, collect and pellet the cells by centrifugation at 3,000 x g for 5 min, remove the supernatant, and stain the cells for 15 min in the dark with the reagent included in cytotoxicity assay.
   4. Determine the number of live HEI-OC1 cells by flow cytometry as indicated by the manufacturer of the flow cytometer.
5. Senescence
   1. Incubate at permissive conditions, usually for 24-48 hr, HEI-OC1 cells in cell culture medium alone (control) or medium plus the drugs of interest.
   2. Determine the number of senescence-associated beta-galactosidase positive cells using flow cytometry with the protocol described by Debacq-Chainiaux et al. ¹⁵ or other method known to provide reliable results. A brief protocol for flow cytometry is the following:
      1. At the end of the experimental treatments, wash the cells three times with PBS and then incubate them with 100 nM Bafilomycin A1 in cell culture medium for 1 hr at permissive conditions.
      2. Add C12FDG at a final concentration of ~33 µM, and continue incubating the cells for 1-2 hr.
      3. Wash the cells twice with PBS, harvest them using 1 ml per 25 cm² of surface area of a non-enzymatic cell dissociation solution for 3 min, and pellet them by centrifugation at 3,000 x g for 5 min.
      4. Resuspend the cells in ice-cold PBS and determine the number of positive HEI-OC1 cells by flow cytometry as indicated by the manufacturer of the flow cytometer.
6. Autophagy
   1. Collect HEI-OC1 cells control and starved (deprived of serum for 48 hr) by following the procedure described in 1.2, and process them for Western blot following standard protocols. In general, the protocols for Western blot have the following steps:
      1. Seed HEI-OC1 cells in 6-well plates at a concentration of 1.0 x 10⁵ cells/ml. After 24 and/or 48 hr, wash the cells with ice-cold PBS.
      2. Lyse with 200 µl of TNESV buffer (1% NP40, 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 2mM EDTA, 1 mM Na₃VO₄) with protease inhibitor cocktail and 1 mM PMSF for 5 min on ice.
      3. Collect the cells (by scraping the bottom of each well), transfer to microcentrifuge tubes and centrifuge at 16,800 x g for 5 min at 4 °C.
      4. Collect the supernatants and quantify the protein concentration using the BCA Assay.
      5. Add 5x loading buffer and 1 mM DTT to each sample and boil for 5 min to denature the proteins.
      6. Run the samples using SDS-PAGE on a 4-12% gel, and transfer to PVDF membranes.
      7. Block the membranes with 5% nonfat dried milk in TBS-T with 0.1% Tween 20 for 60 min at RT.
      8. Incubate the membranes overnight at 4 °C with primary antibodies.
      9. The next day, wash the membranes extensively with TBS-T, and incubate with a secondary IgG antibody conjugated to horseradish peroxidase (HRP) (1:1,500) for 1 hr.
      10. Detect immunoreactivity with an enhanced chemiluminescence (ECL) detection system. Normalize protein expression levels using GAPDH (1:2,000 in TBS-T with in 10% nonfat dried milk) as standard.
   2. In the Western blots investigate the expression of, at least, two different markers of autophagy such as Beclin-1 and LC3B (usually at 1:1,000 dilution in TBS-T with 2.5% BSA). Do not forget to look for a control of protein expression such as GAPDH or actin.
   3. Evaluate the expression of the protein of interest by densitometry using a digital Blot scanner or computer software such as the public domain NIH Image or ImageJ (http://rsb.info.nih.gov/nih-image/).

3. Electrophysiology Experiments with HEI-OC1 Cells

1. Harvesting Cells
   Note: Use cells growing in 100 mm diameter culture dishes at 50%-80% confluency. Trypsin, Accutase, enzyme-free solution, or phosphate- buffered saline + ethylene diamine tetra acetic acid (PBS-EDTA) may be used for lifting the cells without significant effects on the number and quality of the gigaseals. In some cases, however, trypsin treatment makes the cells more fragile. In these cases, allow the cells to recover for approximately 30 minutes before starting the experiments.
   1. Wash the cells twice with 10 ml PBS without Ca²⁺ and Mg²⁺.
   2. Add 2 ml of an enzyme-free detacher solution, such as non-enzymatic cell dissociation solution, and incubate the dishes for 3 min at 37 °C with 5% CO₂.
   3. Use an inverted microscope to check the detachment of the cells. If necessary, move the cell culture dish to detach more cells, but do it gently.
      Note: Do not shake the dish.
   4. Add 10 ml of DMEM+10% FBS and pipette the cells gently up and down five times with a 10-ml pipette.
   5. Look at the cells under a microscope. If > 80% of the cells are already separated (single), no further pipetting is needed. If the cells are still in clusters, repeat the gently pipetting until more than 80% cells are single.
   6. Place the ~10 ml of suspended cells into a 15 ml conical tube, centrifuge for 2 min at 100 x g, and discard the supernatant.
   7. Use ~200 µl of external recording solution (Leibovitz's L-15 medium adjusted to 305 - 310 mOsm with distilled water) to resuspend the cells. An optical control of the cells should show many single, round cells with smooth membrane edges.
2. Patch-clamp and NLC Measurements
   1. Perform patch-clamp and measurements of voltage-dependent nonlinear capacitance (NLC) using adequate amplifiers and software, as well as standard electrophysiological techniques. As internal (intrapipette) solution use 150 mM KCl, 1 mM MgCl₂, 0.1 mM EGTA, 2 mM ATP-Mg, 0.1 mM GTP-Na, and 10 mM HEPES; adjust pH to 7.2 with Tris.
   2. Under the microscope, select a single, healthy cell, with round and smooth membrane edges. Attach the tip of the glass pipette to the cell surface and check membrane resistance. This should be around 3-6 megaOhms, corresponding to an internal diameter (ID) of the tip of the pipette of ~2 µm.
   3. Gently press the micropipette tip against the cell plasma membrane and then apply suction. A portion of the cell membrane will be suctioned into the pipette, generating an electrical resistance in the order of 10 - 100 gigaOhms (gigaseal).
   4. Establish the whole-cell condition by disrupting the plasma membrane with suction pulses.
   5. Use cells that do not express prestin, such as HEK-293, as a control ⁹.
      Note: Current responses should be filtered at 5 kHz, and corrections made for the effects of residual series resistance. All data collection and most analyses can be performed using the software usually included with the lock-in amplifiers. Capacitance function can be fitted to the first derivative of a two state Boltzmann function relating nonlinear charge to membrane voltage ¹⁶.
      
       

结果

In a couple of recent publications we reported a comprehensive set of studies aimed at evaluating the response of HEI-OC1 cells to several commonly used pharmacological drugs as well as investigating prestin function ^8,9. In these studies we made use of all the protocols described in the previous sections.

One of the results of these previous studies was that HEI-OC1 cells cultured at non-permissive conditions (39 °C/...

讨论

In this report we describe how to culture HEI-OC1 cells and use them to evaluate mechanisms of drug-induced cytotoxicity and to investigate functional properties of prestin, the molecular motor of cochlear OHCs. The technical procedures, however, are general enough to be easily adapted to different studies.

All the protocols described here require the correct use of well-established cell culture techniques ¹⁰. Just like with any other cell line, working with HEI-OC1 cells requires a...

材料

本文使用的材料清单

姓名	公司	目录编号	评论
HEI-OC1 细胞			所有 检测试剂盒、设备
II 类生物安全柜	贝克公司	Sterilgard III	和
冷冻离心机	Eppendorf	5810R	中指示的公司 前 2 根色谱柱只是
倒置显微镜		Axiovert 25	示例，以及任何其他类似的
水浴	Stovall	HWB115	产品。
细胞计数仪	Nexcelom	Cellometer Auto T4
两 （2） 个细胞培养箱，一个在 33 °C/10% CO2 等，39 °C/5% CO2	Forma Scientific	3110
细胞培养皿，PS，100 mm x 20 mm，带通风口	Greinier Bio-One	664-160
细胞培养皿，PS，  60 mm x 15 mm，带通风口	Greiner Bio-One	628160
Cellstar 组织培养瓶  250 ml	Greiner Bio-One	658-175
Cellstar 组织培养瓶  550 ml	Greiner Bio-One	660-175
6 孔细胞培养板，带盖-Cellstar	Greiner Bio-One	657-160
微量测试组织培养板，96 孔，平底带盖	Becton Dickinson	353072
微量检测板，Chimmey，96 孔白色，透明底	Greiner Bio-One	655098
50 ml 带盖聚丙烯锥形管 Cellstars	Becton Dickinson	352070
15 ml 带盖聚丙烯锥形管-Cellstars	Greiner Bio-One	188-271
PBS pH 7.4 （1x）	Life Technologies	10010-023
杜尔贝科's 改良鹰's 培养基 （DMEM）	Life Technologies	11965-084
胎牛血清 （FBS）	Hyclone	SH10073.1
Leibovitz's L-15 培养基，无酚红	Gibco/Invitrogen	21083-027
胰蛋白酶，0.25%	Life Technologies	25200-056
TACS MTT细胞增殖检测试剂盒	Trevigen	4890-25-K
Caspase-Glo 3/7检测试剂盒  试剂盒	Promega	G8091
BrdU 细胞增殖检测试剂盒	Cell Signaling	6813
非酶细胞解离溶液	Sigma-Aldrich	C5789
Cell-Tox Green 细胞毒性检测试剂盒	Promega	G8741
FACSAriaIII 仪器	BD生物科学	公司 FACSAriaIII	带 488 nm 激发（蓝色激光）
数字印迹扫描仪	LI-C-DiGit
电泳和印迹装置	Hoefer	SE300 miniVE
Spectra Max 5 读板机，带 Soft Max Pro 5.2 软件	分子器件	SpectraMax 5
膜片钳放大器	HEKA	EPC-10
制备拉拔器贴片电极	Sutter Instruments	P-97